LGR5 in breast cancer and ductal carcinoma in situ: a diagnostic and prognostic biomarker and a therapeutic target. Hagerling C, Owyong M, Sitarama V, Wang CY, et al. BMC Cancer 2020;20:542.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hagerling C, Owyong M, Sitarama V, Wang CY, et al. LGR5 in breast cancer and ductal carcinoma in situ: a diagnostic and prognostic biomarker and a therapeutic target. BMC Cancer 2020;20:542.
PMID: 32522170